Using advanced MRI techniques to improve radiation therapy for prostate cancer
Official title: Quantitative MRI to automatically delineate intraprostatic tumor for radiation therapy
Funded at Beckman Research Institute/city of Hope · NIH-10982242 · Data updated 2026-11-12
This study is working on a new MRI tool to help doctors better see and target prostate cancer tumors during radiation therapy, which could lead to more effective treatments for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beckman Research Institute/city of Hope NIH-funded |
| Lab location | 1 site (Duarte, United States) |
| Project start | July 1, 2024 |
| Project end | June 30, 2029 |
| Funding year | 2024 |
| Award (this year) | $704,563 |
| NIH project number | 1R01CA284172-01A1 |
| Project ID | NIH-10982242 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are men diagnosed with intermediate- to high-risk prostate cancer who are undergoing radiation therapy.
✕Less likely to help
Patients with low-risk prostate cancer or those not receiving radiation therapy may not benefit from this research.
What this research studies
This research focuses on enhancing radiation therapy for prostate cancer by developing a new quantitative MRI tool that can automatically identify and delineate significant tumor areas within the prostate. By utilizing advanced imaging techniques such as magnetic resonance fingerprinting and diffusion-weighted MRI, the project aims to create detailed 3D maps that reflect the tumor's physiological and pathological characteristics. This approach seeks to improve the accuracy of tumor targeting during radiation therapy, potentially leading to better treatment outcomes for patients. The research will also address current limitations in MRI interpretation that can affect treatment decisions.
Why it matters
Potential benefit: If successful, this research could lead to more effective radiation therapy for prostate cancer, improving survival rates and reducing the risk of local recurrences.
How similar studies have gone: Previous research has shown promise in using advanced imaging techniques for cancer treatment, indicating that this approach could lead to significant advancements in prostate cancer therapy.
Where this research is happening
-
Beckman Research Institute/city of Hope
Duarte, United States Active
Researchers
- Principal investigator: Qing, Kun — Beckman Research Institute/city of Hope
- Study coordinator: Qing, Kun
Related research
Other NIH-funded projects on the same topics.
-
Protecting small blood vessels from radiation by boosting mitochondrial health
It aims to prevent radiation-related damage to tiny blood vessels and reduce later thinking and memory problems in people who get radiation therapy by protecting cell mitochondria.
-
Proton SBRT for refractory ventricular tachycardia with real-time 3D/4D imaging
A patient-facing study exploring a proton-based, noninvasive radiation therapy to treat stubborn VT using advanced 3D and 4D imaging to target the heart safely.
-
Embedding symptom support in radiation therapy for prostate cancer
A multi-site study tests whether delivering mindfulness-based symptom support right inside radiation therapy is feasible and acceptable for men with prostate cancer.
-
Targeting SREBP2 to boost radiation therapy in HPV-negative head and neck cancer
This grant aims to see if blocking SREBP2 can make radiation therapy work better for people with HPV-negative Head and Neck Squamous Cell Carcinoma.
-
Genetic and Immune Factors in Squaring the Room: Sacituzumab plus Radiation for Bladder Cancer
A study aims to understand why combining sacituzumab with radiation helps some bladder cancer patients more than others, with the goal of making bladder-sparing therapy more effective.
-
CivaDerm: a new four-day skin cancer radiation bandage
A new four‑day radiation bandage for non-melanoma skin cancer aims to treat facial and other areas without multiple clinic visits or big scars.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.